Results 201 to 210 of about 56,531 (323)

EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Mantle cell lymphoma (MCL) is a relatively rare B‐cell lymphoma subtype, with a higher incidence among males and a median age of 70 years at diagnosis. MCL is characterized by clinically diverse behavior, from indolent disease to extremely aggressive, related to the presence of biological risk factors such as proliferation rate and TP53 ...
Mats Jerkeman, Igor Aurer, Elias Campo, Chan Y. Cheah, Jonathan Clark, Jeanette Doorduijn, Toby A. Eyre, Martin Fehr, Eva Giné, Maria Gomes da Silva, Pavel Klener, Marco Ladetto, Vincent Ribrag, Ofer Shpilberg, Jan Walewski, Martin Dreyling, the EHA Guidelines Committee and the European MCL Network   +16 more
wiley   +1 more source

The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. [PDF]

Genes (Basel)
Singam H, Mossad S.
europepmc   +1 more source

Pharmacists' views on the implementation of therapeutic drug monitoring in oncology

Journal of Pharmacy Practice and Research, Volume 55, Issue 5, Page 414-421, October 2025.
Abstract Background There is increasing interest in the potential benefit of therapeutic drug monitoring (TDM) in oncology. However, uptake in Australian hospitals is limited. Aim This study sought to explore hospital pharmacists' experiences with TDM in oncology, seeking to determine if they could provide insights into barriers and facilitators to its
Jane E. Carland, Bridin Murnion, Thomas Sakellaris, Jana Stojanova   +3 more
wiley   +1 more source

Effects of Treatment with Azoles Are Overstated [PDF]

The American Journal of Medicine, 2017
Maribel Salas, T. Christopher Mast, Hetty Waskin, Neika Vendetti   +3 more
openaire   +3 more sources

The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

, 1997
Theodore C. White
openalex   +1 more source

Evaluation of the Antifungal Properties of Azomethine‐Pyrazole Derivatives from a Structural Perspective

ChemistryOpen, Volume 14, Issue 10, October 2025.
A series of azomethine‐pyrazole derivatives bearing a para‐substituted azo‐phenyl ring is straightforwardly prepared. The new compounds display an elevated antifungal activity against various Candida species and Cryptococcus neoformans strains. DFT and molecular docking calculations are used to determine possible routes of action through interactions ...
María Isabel Murillo, Andrés Camilo Restrepo‐Acevedo, Cristian Rocha‐Roa, Susana Zacchino, Laura Svetaz, Simón Hernández‐Ortega, Rodrigo Abonia, Ronan Le Lagadec, Fernando Cuenú‐Cabezas   +8 more
wiley   +1 more source

Screening for toxicity of azole fungicides in <i>Caenorhabditis elegans</i> identifies triflumizole as a potent reproductive and developmental toxicant. [PDF]

MicroPubl Biol
Hughes S, Koopmans C, van Duursen M.
europepmc   +1 more source

Mechanisms of resistance to azole antifungals.

, 1995
Patrick Marichal, H. Vanden Bossche
openalex   +1 more source

The serine palmitoyl transferase of plant pathogenic fungi: a promising new target for the development of novel crop protection solutions†

Pest Management Science, Volume 81, Issue 10, Page 6567-6578, October 2025.
High biological activity of pyridazine carboxamides against a wide range of Ascomycetes led to identification of a new biochemical target for agrochemical fungicides – serine palmitoyl transferase. Abstract BACKGROUND Plant pathogens pose a significant threat to global agriculture and, thus to world food supplies, requiring the development of ...
Lionel Nicolas, Emilia Hilz, Stephanie Gamet, Vincent Thomas, Stephane Peyrard, Luigi Di Vietro, Benedicte Cirer, Julie Geist, Bernd Essigmann, Anne Ferry, Angeline Chanel, Frédéric Berniaud, Dominik Schwarz, Virginie Lempereur   +13 more
wiley   +1 more source

Successful Treatment of Mucormycosis and Azole-Resistant <i>Aspergillus</i> Coinfection in a Diabetic Patient: A Case Report. [PDF]

Infect Drug Resist
Zhao T, Fang Y, Wu Q, Shi M, Ni Y, Zou R, Liu M, Wu W, Su X.   +8 more
europepmc   +1 more source